Miguel Goicoechea

804 total citations
24 papers, 572 citations indexed

About

Miguel Goicoechea is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Miguel Goicoechea has authored 24 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Virology and 5 papers in Immunology. Recurrent topics in Miguel Goicoechea's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Miguel Goicoechea is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Miguel Goicoechea collaborates with scholars based in United States, Spain and United Kingdom. Miguel Goicoechea's co-authors include Brookie M. Best, Richard Haubrich, Carol A. Kemper, Catherine Diamond, Mallory D. Witt, Sonia Jain, Shelly Sun, Stan G. Louie, Shanshan Liu and Davey M. Smith and has published in prestigious journals such as The Journal of Infectious Diseases, The American Journal of Gastroenterology and AIDS.

In The Last Decade

Miguel Goicoechea

18 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Goicoechea United States 10 467 282 183 129 44 24 572
Natascia Sala Italy 9 316 0.7× 250 0.9× 215 1.2× 112 0.9× 79 1.8× 12 480
Christiane Moecklinghoff Germany 14 592 1.3× 492 1.7× 258 1.4× 103 0.8× 21 0.5× 34 728
Dan Duiculescu Romania 11 805 1.7× 628 2.2× 219 1.2× 225 1.7× 21 0.5× 22 949
Homayoon Khanlou United States 8 525 1.1× 374 1.3× 181 1.0× 110 0.9× 17 0.4× 16 616
Arkaitz Imaz Spain 16 574 1.2× 390 1.4× 111 0.6× 221 1.7× 11 0.3× 81 744
Judy Johnson United States 14 459 1.0× 424 1.5× 92 0.5× 100 0.8× 24 0.5× 19 617
Maura Laverty United States 8 356 0.8× 243 0.9× 59 0.3× 181 1.4× 14 0.3× 15 517
Ellen Koenig United States 12 760 1.6× 533 1.9× 275 1.5× 145 1.1× 10 0.2× 23 822
Joseph J. Eron United States 16 978 2.1× 734 2.6× 297 1.6× 186 1.4× 22 0.5× 29 1.1k
Janet Nicotera United States 8 389 0.8× 266 0.9× 84 0.5× 182 1.4× 17 0.4× 12 515

Countries citing papers authored by Miguel Goicoechea

Since Specialization
Citations

This map shows the geographic impact of Miguel Goicoechea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Goicoechea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Goicoechea more than expected).

Fields of papers citing papers by Miguel Goicoechea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Goicoechea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Goicoechea. The network helps show where Miguel Goicoechea may publish in the future.

Co-authorship network of co-authors of Miguel Goicoechea

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Goicoechea. A scholar is included among the top collaborators of Miguel Goicoechea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Goicoechea. Miguel Goicoechea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goicoechea, Miguel, et al.. (2024). S4666 A Rare Presentation of CMV Gastritis, Duodenitis, and Colitis in a Patient With Autoimmune Hepatitis on Immunosuppressive Therapy. The American Journal of Gastroenterology. 119(10S). S2954–S2954.
3.
Goicoechea, Miguel, et al.. (2023). 1ISG-001 Economic impact generated by natalizumab optimisation. A5.1–A5. 1 indexed citations
4.
Goicoechea, Miguel, et al.. (2023). 4CPS-133 Safety and effectiveness of guselkumab on moderate to severe plaque psoriasis. Section 4: Clinical pharmacy services. A66.3–A67.
5.
Goicoechea, Miguel, et al.. (2018). No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients: A Real-world Experience. Open Forum Infectious Diseases. 5(12). ofy192–ofy192. 16 indexed citations
6.
Karris, Maile, Sonia Jain, Josué Pérez‐Santiago, et al.. (2017). HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. HIV Clinical Trials. 18(2). 67–74. 1 indexed citations
7.
Goicoechea, Miguel, et al.. (2016). CP-233 Effectiveness of regorafenib in the treatment of metastatic colorectal cancer in selected patients. A103.1–A103. 1 indexed citations
8.
9.
Beliakova‐Bethell, Nadejda, Sonia Jain, Christopher H. Woelk, et al.. (2014). Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression. Antiviral Research. 107. 42–49. 11 indexed citations
10.
Cachay, Edward R., David Wyles, Miguel Goicoechea, et al.. (2011). Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment. AIDS Research and Therapy. 8(1). 29–29. 4 indexed citations
11.
Goicoechea, Miguel, Sonia Jain, Carol A. Kemper, et al.. (2010). Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 24(5). 707–716. 13 indexed citations
12.
Goicoechea, Miguel, Sonia Jain, Shelly Sun, et al.. (2009). Interlaboratory Measurement Differences in Intracellular Carbovir Triphosphate Concentrations in HIV‐Infected Patients: Sources of Variability in Processing, Shipping, and Quantitation. The Journal of Clinical Pharmacology. 50(8). 968–974. 5 indexed citations
13.
Woelk, Christopher H., Nadejda Beliakova‐Bethell, Miguel Goicoechea, et al.. (2009). Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS. 24(2). 217–222. 18 indexed citations
14.
Best, Brookie M. & Miguel Goicoechea. (2008). Efavirenz – Still First-line King?. Expert Opinion on Drug Metabolism & Toxicology. 4(7). 965–972. 37 indexed citations
15.
Goicoechea, Miguel & Brookie M. Best. (2007). Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?. Expert Opinion on Pharmacotherapy. 8(3). 371–382. 23 indexed citations
16.
Goicoechea, Miguel, Shanshan Liu, Brookie M. Best, et al.. (2007). Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy. The Journal of Infectious Diseases. 197(1). 102–108. 235 indexed citations
17.
Best, Brookie M., Miguel Goicoechea, Mallory D. Witt, et al.. (2007). A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and -Experienced HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(4). 433–442. 31 indexed citations
18.
19.
Wagner, Glenn J., David E. Kanouse, Daniela Golinelli, et al.. (2006). Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 20(9). 1295–1302. 66 indexed citations
20.
Goicoechea, Miguel, Davey M. Smith, Lin Liu, et al.. (2006). Determinants of CD4+T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV‐1 DNA. The Journal of Infectious Diseases. 194(1). 29–37. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natascia Sala Breakdown of academic impact, for papers by Christiane Moecklinghoff Breakdown of academic impact, for papers by Dan Duiculescu Breakdown of academic impact, for papers by Homayoon Khanlou Breakdown of academic impact, for papers by Arkaitz Imaz Breakdown of academic impact, for papers by Judy Johnson Breakdown of academic impact, for papers by Maura Laverty Breakdown of academic impact, for papers by Ellen Koenig Breakdown of academic impact, for papers by Joseph J. Eron Breakdown of academic impact, for papers by Janet Nicotera
Rankless by CCL
2026